Book description
Asia is increasingly taking on a leading role in the fields of Good Clinical Practice (GCP) and ethics, two areas that are central to clinical research practices worldwide. Clinical research in Asia examines the evolution of these key sectors in the Asian countries where the greatest developments are taking place, offering valuable perspectives on a wide range of issues affecting clinical research. Following an introduction that provides an overview of the topic and its strengths and weaknesses, each chapter of the book is devoted to clinical research in a specific country, focusing on issues including the history and evolution of clinical research, clinical trials and regulatory aspects. The chapters also offer a perspective on future trends in clinical research in each country. The book concludes with a discussion of the importance of political, economic, socio-cultural, technological, legal and environmental factors (PESTLE analysis).- Analysis from a leading and highly respected professional in the sector
- An overview of country-specific regulatory environments
- Discussion of challenges and solutions for clinical research
Table of contents
- Cover image
- Title page
- Table of Contents
- Dedication
- Copyright
- List of figures and table
- Acknowledgments
- List of abbreviations
- Preface
- About the author
-
Chapter 1: Clinical research in Asia: a brief overview
- Abstract:
- 1.1 Background
- 1.2 Global pharmaceutical market
- 1.3 Clinical research business – a global overview
- 1.4 CRO services mix
- 1.5 The clinical research boom in Asia
- 1.6 Asian country segmentation analysis
- 1.7 Clinical trials in Asia
- 1.8 Inspection and data quality
- 1.9 Clinical research in Asia – SWOT analysis
-
Chapter 2: Clinical research in Japan
- Abstract:
- 2.1 Background and history
- 2.2 Clinical research industry in Japan
- 2.3 The regulatory environment in Japan
- 2.4 Evolution of Japanese good clinical practice
- 2.5 Global clinical trials in Japan
- 2.6 Emerging outsourcing models in Japan
- 2.7 Japan’s international strategic outlook
- 2.8 Future outlook
-
Chapter 3: Clinical research in India
- Abstract:
- 3.1 Pharmaceutical industry background
- 3.2 History of clinical research in India
- 3.3 Evolution of clinical research in India
- 3.4 Regulatory environment in India
- 3.5 Clinical trial approval
- 3.6 Difference between ICH-GCP and Indian GCP
- 3.7 Regulatory inspections in India
- 3.8 Clinical research in India: PESTLE analysis
- 3.9 Future outlook
-
Chapter 4: Clinical research in China
- Abstract:
- 4.1 Pharmaceutical market
- 4.2 Pharmaceutical investments in China
- 4.3 China’s healthcare system
- 4.4 Healthcare delivery system
- 4.5 The importance of traditional medicine in modern healthcare
- 4.6 China’s CRO market
- 4.7 Clinical trials in China
- 4.8 Accreditation of clinical trial sites in China
- 4.9 Clinical research in China – environmental analysis
- 4.10 Future outlook
- Chapter 5: Clinical research in South Korea
- Chapter 6: Clinical research in Taiwan
-
Chapter 7: Clinical research in Singapore
- Abstract:
- 7.1 Overview of the pharmaceutical industry in Singapore
- 7.2 Pharmaceutical investments in Singapore
- 7.3 Governing authority and regulatory structure
- 7.4 Healthcare system in Singapore
- 7.5 Clinical research in Singapore
- 7.6 CRO market
- 7.7 Clinical trials in Singapore
- 7.8 Evolution of GCP in Singapore
- 7.9 Role of clinical trial resource centre
- 7.10 Environmental analysis
- 7.11 Clinical trial challenges
- 7.12 Future outlook
-
Chapter 8: Clinical research in Thailand
- Abstract:
- 8.1 Pharmaceutical industry in Thailand
- 8.2 The pharmaceutical regulatory environment
- 8.3 Pharmaceutical market
- 8.4 Clinical research in Thailand
- 8.5 CRO market in Thailand
- 8.6 Hospital systems in Thailand
- 8.7 Conducting clinical trials in Thailand
- 8.8 Clinical trials in Thailand
- 8.9 Environmental analysis
- 8.10 Future outlook
-
Chapter 9: Clinical research in Malaysia
- Abstract:
- 9.1 Pharmaceutical industry overview
- 9.2 Pharmaceutical market
- 9.3 Pharmaceutical regulation
- 9.4 Healthcare systems in Malaysia
- 9.5 Clinical trial environment
- 9.6 Regulatory environment in Malaysia
- 9.7 Evolution of Malaysian GCP
- 9.8 CRO market in Malaysia
- 9.9 Clinical trials in Malaysia
- 9.10 Registration of clinical trials
- 9.11 Challenges and future outlook
- Chapter 10: Clinical research in Hong Kong
- Chapter 11: Clinical research in the Philippines, Indonesia Vietnam
- Chapter 12: Conclusions
- Bibliography
- Index
Product information
- Title: Clinical Research in Asia
- Author(s):
- Release date: May 2012
- Publisher(s): Woodhead Publishing
- ISBN: 9781908818133
You might also like
book
Success Built to Last: Creating a Life that Matters
Chosen by BusinessWeek as one of the top 5 books of 2006 in careers. Read the …
book
Marketing 3.0: From Products to Customers to the Human Spirit
Understand the next level of marketing The new model for marketing- Marketing 3.0-treats customers not as …
book
The Power of foursquare: 7 Innovative Ways to Get Your Customers to Check In Wherever They Are
Connect with Your Customers. Anytime. Anywhere. One million new users per month. Twenty-three check-ins per second. …
book
Bioinformatics for Biomedical Science and Clinical Applications
Contemporary biomedical and clinical research is undergoing constant development thanks to the rapid advancement of various …